Recombinant Epidermal Growth Factor (EGF) Proteins
8 products
8 products
Epidermal Growth Factor (EGF) plays a central role in cell biology by stimulating cell growth, proliferation, and differentiation through its interaction with the EGF receptor (EGFR). First discovered in the 1960s, EGF has since become one of the most studied growth factors, especially due to its applications in tissue repair and regenerative medicine. At Beta LifeScience, we offer a curated collection of recombinant human EGF proteins to support research in areas like oncology, wound healing, cell therapy, and stem cell biology.
EGF’s biological influence goes far beyond the epidermis. It affects various systems across the body, including the nervous system, gastrointestinal tract, and even the immune response. In scientific studies, human recombinant EGF is frequently used to culture epithelial cells, accelerate tissue repair, and analyze EGFR-related signal transduction. Whether you’re developing targeted therapies or advancing your understanding of cellular behavior, high-purity recombinant EGF proteins are essential for consistent and reproducible results.
In this collection, you’ll find active and GMP-grade EGF recombinant human proteins produced in different host systems, including E. coli, yeast, and mammalian cells. Every protein undergoes stringent testing to ensure high bioactivity and purity, making them reliable tools for a range of experimental protocols.
EGF is a small polypeptide growth factor that triggers downstream cellular processes by binding to its receptor, EGFR, a transmembrane tyrosine kinase. The binding of recombinant human EGF to EGFR initiates a cascade of intracellular signals that promote:
This makes recombinant EGF a powerful component in tissue engineering, cosmetic development, and cancer biology studies. Researchers often integrate EGF recombinant human protein into cell culture media to improve viability, especially in epithelial and stem cell lines.
Cat. No. | Species | Product Description | Host | Structure | Purity | Activity | Features |
---|---|---|---|---|---|---|---|
BLPSN-1714 | Human | Human EGF Protein (Fc Tag), Active | Mammalian Cells | P01133 (971-1023aa) | > 90 % | ED50: 0.3-1.5 ng/mL. | SDS-PAGE,Cell Based |
BLC-08407P | Human | Human Pro-EGF Protein (GST) | E.coli | P01133 (977-1023aa) | > 90 % | Not Test | SDS-PAGE |
BLC-05995P | Human | Human EGF Protein, Active, GMP | E.Coli | P01133 (971-1023aa) | > 98 % | ED50 is less than 0.1 ng/ml | SDS-PAGE,Cell Based,HPLC |
BLC-05958P | Human | Human EGF Protein, Active | E.coli | P01133 (971-1023aa) | >95% | ED50: 0.1-0.5 ng/ml | SDS-PAGE |
BLC-06005P | Human | Human Pro-EGF Protein, Active | E.coli | P01133 (971-1023aa) | >95% | ED50is less than 1 ng/ml | SDS-PAGE,Cell Based,HPLC |
BLPSN-1712 | Human | Human EGF Protein, Active | E. coli | P01133 (971-1023aa) | ≥ 95 % | ED50: 0.02-0.2ng/ml. | SDS-PAGE,Cell Based,HPLC |
BL-1779NP | Human | Human EGF Protein, Active | E. coli | P01133 (971-1023aa) | >95% | ED50: 60-450 pg/ml. | SDS-PAGE,Cell Based |
BLPSN-1717 | Mouse | Mouse EGF Protein (Fc Tag), Active | Mammalian Cells | P01132 (977-1029aa) | > 95 % | ED50: 0.5-3 ng/mL. | SDS-PAGE,Cell Based |
BLPSN-1716 | Mouse | Mouse EGF Protein, Active | Yeast | P01132 (977-1029aa) | > 95 % | ED50: 30-180 pg/mL. | SDS-PAGE,Cell Based |
BLC-05925P | Mouse | Mouse Pro-EGF Protein (His), Active | E.coli | P01132 (977-1029aa) | >95% | ED50 is less than 5 ng/ml. | SDS-PAGE,Cell Based |
BL-0281NP | Mouse | Mouse EGF Protein (C-6His), Active | E. coli | P01132 (977-1029aa) | >95% | ED50: 2-20 ng/ml. | SDS-PAGE,Cell Based |
BLPSN-1719 | Rat | Rat EGF Protein, Active | E. coli | P07522 (974-1026aa) | > 95 % | ED50: 0.05-0.3ng/mL. | SDS-PAGE,Cell Based |
BLPSN-1710 | Canine | Canine EGF Protein (His Tag), Active | E. coli | Q9BEA0 (973-1024aa) | ≥ 95 % | EC50: 0.5-3 ng/ml. | SDS-PAGE,Cell Based |
BLPSN-1709 | Canine | Canine EGF Protein, Active | Yeast | Q9BEA0 (973-1024aa) | > 95 % | ED50: 0.1-0.6 ng/mL. | SDS-PAGE,Cell Based |
While EGF’s regenerative potential is widely valued, its dysregulation has been linked to multiple diseases, including:
Due to these factors, EGF recombinant human protein is a focal point of targeted therapeutic research. EGFR inhibitors, for example, are commonly used in anti-cancer drugs, making the study of recombinant EGF essential for preclinical validation.
Researchers, biotech labs, and pharmaceutical companies rely on recombinant human EGF for applications such as:
Our recombinant EGF proteins are produced with precision and tested rigorously for bioactivity, structural integrity, and purity. Here’s what makes our catalog stand out:
If your research explores other signaling pathways or regenerative biology models, you may also want to explore:
Recombinant human EGF remains a cornerstone of modern biological and medical research. Whether you're modeling cancer progression, optimizing tissue culture conditions, or developing regenerative therapies, our high-performance EGF recombinant human proteins are tailored to help you achieve robust and reproducible outcomes.
At Beta LifeScience, we combine scientific precision with convenience—giving you access to well-characterized human recombinant EGF proteins that meet the demands of innovative research. Every vial you receive has been backed by rigorous validation and manufactured with quality at its core. Ready to elevate your next experiment? Explore our collection of recombinant EGF proteins today.